Around 1 in 5 people diagnosed with cancer in the UK take part in a clinical trial.
A study looking at the causes of Hodgkin lymphoma
We know that this is an especially worrying time for people with cancer and their family and friends. We have separate information about coronavirus and cancer. Please read that information alongside this page. We will update that information as guidance changes.
In this study researchers wanted to look at the possible causes of Hodgkin lymphoma. The study was for children as well as adults.
More about this trial
Summary of results
- several new genes that may increase the risk of developing HL
- out more about cells in the immune system called T cells, comparing lymph nodes of people with and without HL
- the differences between the genes in HL that is associated with the Epstein Barr virus (EBV), and HL that isn’t
- the proteins in HL cells which affect how the cells divide and grow
- more about the importance of the EBV in the development of HL
- that the differences in how HL behaves depends on whether it is associated with EBV or not
- that having the measles virus does not appear to be related to the development of HL
- that a group of viruses called polyomaviruses don’t appear to increase the risk of developing HL
How to join a clinical trial
Professor Ruth Jarrett
NIHR Clinical Research Network: Cancer
University of Glasgow